FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2023
Back to search
Official data from USPTO
ONE BIOMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
08/07/2023
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 9, 10
Filing date
07/13/2021
Registration date
03/28/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SG
Examiner
BENMAMAN, ALICE
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording ONE with a dot in the top right corner of the "O," above the stylized wording BIOMED.
Holders and representatives
Holders
One BioMed Pte Ltd
Representatives
Christopher M. Thomas Parker Poe Adams & Bernstein LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposesreagents and solvents for scientific and research use for the preparation of samplesthe modification and manipulation of samples and for performing markingseparationisolationpurificationreproduction and analysis methods for biopolymersnamely nucleic acidsproteinsmacromolecules and biologically active substances; kits comprised primarily of chemical preparationsnamely reagentssolventsenzymesbuffer solutionsfor scientific purposes for the preparation of samplesthe modification and manipulation of samples and for the markingseparationisolationpurificationreproduction and the analysis of biopolymersnamely nucleic acidsproteinsmacromoleculesbiologically active substancesin the nature of nucleic acids from biological and biochemical sample material
Class 5
Productsdiagnostic reagentssolventsenzymesbuffer solutions for medical use for the preparationmodificationmanipulation of samplesfor markingseparatingisolatingpurifyingreproducinganalyzing biopolymersnucleic acidsproteinsmacromolecules and biologically active substances in the field of human and veterinary medicine; chemicalbiochemical and biotechnological productsdiagnostic reagents and solvents for medical use for the preparationmodificationmanipulation of samplesfor markingseparatingisolatingpurifyingreproducinganalyzing biopolymersnucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits comprised primarily of diagnostic preparationsreagentssolventsenzymesbuffer solutionsfor medical and veterinary medical diagnostic purposesthe preparationmodificationmanipulation of samplesfor markingseparatingisolatingpurifyingreproducinganalyzing biopolymersnucleic acidsproteinsmacromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material; cartridges sold pre-filled with reagents for sample preparation and analysis for medical or veterinary diagnostic use
Class 9
Scientific apparatusinstruments and equipmentin particular for research and diagnostic purposessample preparation devices in the nature of integrated molecular platformsbio-separation devices for the preparationmodification and manipulation of samplesfor the markingseparationisolationpurificationreproduction and analysis of biopolymersnamely nucleic acidsproteinsmacromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material
Class 10
Medical apparatusinstruments and equipment for medical analysis and determination of nucleic acids to assess the medical condition of a human or animalthermo-optical analyser for medical purposes to assess the medical condition of a human or animal
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/14/2023
FIMP
FINAL DISPOSITION PROCESSED
07/14/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/28/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/14/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/22/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/30/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/27/2022
GNFR
FINAL REFUSAL E-MAILED
06/27/2022
CNFR
FINAL REFUSAL WRITTEN
06/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2022
RFNT
REFUSAL PROCESSED BY IB
12/06/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/18/2021
RFRR
REFUSAL PROCESSED BY MPU
11/18/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/22/2021
CNRT
NON-FINAL ACTION WRITTEN
10/21/2021
DOCK
ASSIGNED TO EXAMINER
10/21/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2021
Continuous trademark protection
Get notified about every new filing that threatens ONE BIOMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.